Video Shorts

1:00
The Health Beat: Experts Confidence in CDC Measles Reports
11 hours ago
by
Kevin Kunzmann(+1 more)

0:42
The Federal Regulatory Vaccine Policy Environment Today
7 days ago
by
Robert H. Hopkins Jr. MD(+1 more)

1:05
Advocating for the PASTEUR Act
7 days ago
by
Amanda Jezek(+1 more)

1:15
The Limited CDC Response to the Measles Outbreak
11 days ago
by
Paul Offit, MD(+1 more)

1:40
When Will Enough Be Enough to Address Measles?
13 days ago
by
Paul Offit, MD(+1 more)

0:52
Procedures After Doffing PPE in High-Consequence Pathogen Environment
25 days ago
by
Jill Morgan, RN, BSN(+1 more)

1:04
Monitoring Healthcare Workers After High-Consequence Pathogen Exposure
25 days ago
by
Jill Morgan, RN, BSN(+1 more)

0:39
Challenges of Acquiring Phage Therapy
4 months ago
by
Ashlan Kunz Coyne, PharmD, MPH(+1 more)

0:48
Building Parents' Trust About Childhood Vaccines
4 months ago
by
Ruth Lynfield, MD(+1 more)

0:14
A Monoclonal Antibody as a COVID-19 Alternative
4 months ago
by
Robert Allen, PhD(+1 more)

0:36
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
4 months ago
by
Barry Kreiswirth, PhD(+1 more)

0:36
The Center for Discovery and Innovation’s Commitment to Fungal Diagnostics and Treatment
4 months ago
by
David Perlin, PhD(+1 more)

0:41
Kevin Ault, MD on ACIP Shared Decision-Making, Informed Consent, and Vaccine Policy
5 months ago
by
Kevin Ault, MD(+1 more)

0:52
Adoption of Rapid Diagnostic Tools, Susceptibility Testing for Gram-Negative Infections
5 months ago
by
Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; and Ryan P. McNamara, PhD(+1 more)

0:26
Why Intestinal Antibodies Are Key to Beating Norovirus Infection
5 months ago
by
Sean N Tucker, PhD(+1 more)

0:22
Examining Chronic Chikungunya and Potential Clues to Rheumatologic Symptoms
5 months ago
by
Daniela Weiskopf, PhD(+1 more)

0:28
Clinical Considerations for Using Newer Antibiotics for Gram-Negative Infections
5 months ago
by
Ryan K. Shields, PharmD, MS(+1 more)
Advertisement
Advertisement
Trending on Contagion Live
1
Novel Single-Tablet Regimen Demonstrates Noninferiority to Standard HIV Therapy
2
Traws Pharma Reports Differentiated COVID-19 and Influenza Antiviral Progress
3
Switching to Doravirine/Islatravir Maintains Viral Suppression Through 96 Weeks
4
Measles Update: February 20, 2026
5
